Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
2.440
-0.145 (-5.61%)
At close: Jun 27, 2025, 4:00 PM
2.450
+0.010 (0.41%)
After-hours: Jun 27, 2025, 4:00 PM EDT
Evaxion Employees
Evaxion had 46 employees as of December 31, 2024. The number of employees decreased by 3 or -6.12% compared to the previous year.
Employees
46
Change (1Y)
-3
Growth (1Y)
-6.12%
Revenue / Employee
$71,587
Profits / Employee
-$290,022
Market Cap
15.41M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
EVAX News
- 3 days ago - Evaxion expands R&D pipeline with new vaccine program targeting Group A Streptococcus - GlobeNewsWire
- 25 days ago - Evaxion receives grant funding to design new polio vaccine - GlobeNewsWire
- 4 weeks ago - Evaxion Biotech A/S (EVAX) Q1 2025 Earnings Conference Call Transcript - Seeking Alpha
- 4 weeks ago - Evaxion announces business update and first quarter 2025 financial results - GlobeNewsWire
- 4 weeks ago - Evaxion: Progress Unrecognized By Market And A Catalyst-Full 2025 - Seeking Alpha
- 5 weeks ago - Evaxion to announce business update and first quarter 2025 financial results on May 27, 2025 - GlobeNewsWire
- 5 weeks ago - Evaxion doses first patient in extension of phase 2 trial exploring the full potential of AI-designed personalized cancer vaccine EVX-01 - GlobeNewsWire
- 2 months ago - 80% of the EVX-01 vaccine targets trigger a tumor-reactive immune response - Evaxion presents striking EVX-01 data at the AACR Annual meeting - GlobeNewsWire